Reported Earnings • May 12
Full year 2025 earnings released: €0.18 loss per share (vs €0.13 loss in FY 2024) Full year 2025 results: €0.18 loss per share (further deteriorated from €0.13 loss in FY 2024). Revenue: €35.7m (down 4.3% from FY 2024). Net loss: €2.38m (loss widened 37% from FY 2024). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Announcement • May 07
Altheora SA, Annual General Meeting, Jun 16, 2026 Altheora SA, Annual General Meeting, Jun 16, 2026. Location: 3 rue des condamines, mauves France New Risk • Apr 21
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (€7.00m market cap, or US$8.23m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (9.7% average weekly change). New Risk • Dec 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (€6.39m market cap, or US$7.53m). New Risk • Nov 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€5.50m market cap, or US$6.39m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (7.7% average weekly change). New Risk • Aug 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.39m market cap, or US$7.43m). Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 6 highly experienced directors. Independent Director Franck Colcombet was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • May 22
New major risk - Revenue and earnings growth Earnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€4.60m market cap, or US$5.19m). Announcement • May 05
Altheora SA, Annual General Meeting, Jun 10, 2025 Altheora SA, Annual General Meeting, Jun 10, 2025. Location: 3 rue des condamines, mauves France New Risk • May 02
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (€4.35m market cap, or US$4.91m). New Risk • Nov 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 74% per year over the past 5 years. Market cap is less than US$10m (€4.98m market cap, or US$5.24m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Reported Earnings • May 02
Full year 2023 earnings released: €0.25 loss per share (vs €0.21 loss in FY 2022) Full year 2023 results: €0.25 loss per share (further deteriorated from €0.21 loss in FY 2022). Revenue: €41.7m (up 18% from FY 2022). Net loss: €2.02m (loss widened 19% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance. Reported Earnings • Oct 20
First half 2023 earnings released: €0.033 loss per share (vs €0.043 loss in 1H 2022) First half 2023 results: €0.033 loss per share. Revenue: €23.0m (up 15% from 1H 2022). Net loss: €436.0k (loss widened 30% from 1H 2022). New Risk • Sep 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (73% increase in shares outstanding). Market cap is less than US$10m (€7.76m market cap, or US$8.27m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (7.8% average weekly change). New Risk • Sep 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (73% increase in shares outstanding). Market cap is less than US$10m (€9.16m market cap, or US$9.88m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (7.6% average weekly change). Announcement • Dec 10
Altheora SA announced that it expects to receive €6 million in funding Altheora SA announced a private placement for gross proceeds of approximately €6 million on December 8, 2022. The transaction will include participation from individual investors via the PrimaryBid platform. The company will issue common shares in the transaction. Announcement • Dec 01
Altheora Enters into Exclusive Negotiations for an Acquisition Altheora SA (ENXTPA:ALORA) enters into exclusive negotiations for an acquisition. The company announced opening of exclusive negotiations in view of acquiring 100% of capital of a company expert in thermoplastic injection parts. The group may soon consider going to market to finance this acquisition project. Price Target Changed • Nov 16
Price target decreased to €1.90 Down from €2.10, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €1.53. Stock is down 17% over the past year. The company is forecast to post a net loss per share of €0.033 next year compared to a net loss per share of €0.029 last year. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 13
First half 2022 earnings released First half 2022 results: Revenue: €20.1m (up 17% from 1H 2021). Net loss: €336.0k (down €350.0k from profit in 1H 2021). Revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Electrical industry in France. Price Target Changed • Sep 28
Price target decreased to €1.90 Down from €2.20, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €1.53. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.059 next year compared to a net loss per share of €0.029 last year. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 18
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: €0.029 loss per share (up from €0.04 loss in FY 2020). Revenue: €32.6m (up 28% from FY 2020). Net loss: €228.0k (loss narrowed 27% from FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 8.0%, compared to a 9.9% growth forecast for the industry in France. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance. Price Target Changed • Feb 22
Price target decreased to €2.40 Down from €2.60, the current price target is provided by 1 analyst. New target price is 36% above last closing price of €1.76. Stock is down 5.4% over the past year. The company is forecast to post earnings per share of €0.048 next year compared to a net loss per share of €0.04 last year. Announcement • Dec 18
Altheora Group Enters Exclusive Negotiations to Acquire Edel Tamp Altheora SA (ENXTPA:ALORA) announced on December 16, 2021 that it has entered into exclusive negotiations with a view to acquiring Edel Tamp Unite Heyrieux - Edel Tamp U.H. The acquisition is expected to be completed in early 202. This acquisition also enables the group to move closer to its ambition to give the group the means to reach an initial target of €50 million in consolidated turnover by 2023. Reported Earnings • Oct 23
First half 2021 earnings released: EPS €0.002 (vs €0.021 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €17.2m (up 47% from 1H 2020). Net income: €14.0k (up €177.6k from 1H 2020). Profit margin: 0.1% (up from net loss in 1H 2020). Board Change • Sep 20
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 14
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 13
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 08
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 06
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 04
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. CEO, MD & Director Benedicte Durand was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • Feb 03
Price target raised to €2.40 Up from €2.20, the current price target is provided by 1 analyst. The new target price is 28% above the current share price of €1.88. As of last close, the stock is down 12% over the past year. Is New 90 Day High Low • Jan 04
New 90-day high: €1.99 The company is up 15% from its price of €1.72 on 06 October 2020. The French market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electrical industry, which is up 9.0% over the same period. Is New 90 Day High Low • Nov 27
New 90-day high: €1.90 The company is up 6.0% from its price of €1.80 on 28 August 2020. The French market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electrical industry, which is up 10.0% over the same period. Is New 90 Day High Low • Oct 22
New 90-day low: €1.59 The company is down 15% from its price of €1.88 on 24 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electrical industry, which is up 4.0% over the same period. Is New 90 Day High Low • Sep 22
New 90-day low: €1.71 The company is down 5.0% from its price of €1.79 on 24 June 2020. The French market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electrical industry, which is up 10.0% over the same period.